Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$62.93 - $90.59 $456,116 - $656,596
-7,248 Closed
0 $0
Q1 2021

May 12, 2021

SELL
$88.19 - $140.01 $125,053 - $198,534
-1,418 Reduced 16.36%
7,248 $686,000
Q4 2020

Feb 12, 2021

SELL
$87.69 - $130.94 $190,550 - $284,532
-2,173 Reduced 20.05%
8,666 $1.06 Million
Q3 2020

Nov 12, 2020

SELL
$56.99 - $89.33 $359,492 - $563,493
-6,308 Reduced 36.79%
10,839 $947,000
Q2 2020

Aug 13, 2020

BUY
$39.94 - $70.39 $153,888 - $271,212
3,853 Added 28.98%
17,147 $1.11 Million
Q1 2020

May 12, 2020

SELL
$32.02 - $66.17 $207,393 - $428,583
-6,477 Reduced 32.76%
13,294 $594,000
Q4 2019

Feb 11, 2020

BUY
$35.56 - $63.25 $329,747 - $586,517
9,273 Added 88.33%
19,771 $1.23 Million
Q3 2019

Nov 12, 2019

BUY
$36.9 - $57.76 $387,376 - $606,364
10,498 New
10,498 $395,000

About Turning Point Therapeutics, Inc.


  • Ticker TPTX
  • Exchange NASDAQ
  • Shares Outstandng 50,074,300
More about TPTX
Track This Portfolio

Track Advisory Research Inc Portfolio

Follow Advisory Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Research Inc with notifications on news.